CliffBio
small molecule

ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE

ALBUTEROL SULFATE; IPRATROPIUM BROMIDE

Loss of exclusivity—loss of exclusivity
CompanyCipla →See this company's full patent-cliff portfolio

Drug detail

Brand nameALBUTEROL SULFATE AND IPRATROPIUM BROMIDE
Active ingredientALBUTEROL SULFATE; IPRATROPIUM BROMIDE
StrengthEQ 0.083% BASE;0.017%
Dosage formSOLUTION
RouteINHALATION
ModalitySmall molecule
FDA approvalDecember 2007
Marketing statusRX

More from Cipla

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE patent cliff — loss of exclusivity — | CliffBio